New radiation approach aims to safely treat Hard-to-Reach lung tumors
NCT ID NCT06712745
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This early-stage study tests a personalized radiation technique called PULSAR for lung cancers located near the center of the chest. The goal is to make treatment safer while still effectively controlling the tumor. About 30 adults with primary or metastatic lung cancer will receive this tailored radiotherapy, and researchers will monitor tumor response and survival.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER, LUNG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New imaging agent could sharpen cancer detection
- Lung cancer radiation: new study tracks breathing side effects
- Tiny tumor clusters may predict colon cancer outcomes
- Zapping resistant tumors: could targeted radiation buy more time for prostate cancer patients?
- Surgery plus drugs may extend life in advanced liver cancer
- New drug combo takes aim at KRAS-Mutant lung cancer